Key Event Details
AstraZeneca Pharma India Limited received an order from the Deputy Commissioner of State Tax (Appeal) on June 3, 2026. The order was passed under section 107 of the Maharashtra Goods and Services Act, 2017 and pertains to the financial year 2018-19.
Background of Dispute
This order represents a development in an appeal originally filed by the company on June 29, 2020. The appeal was against an order issued by the Assistant Commissioner of State Tax Investigation, which had been previously intimated to the stock exchanges on August 14, 2023.
Details of the Dispute
The dispute concerns certain adjustments initially made by the Assistant Commissioner of State Tax Investigation relating to supplies made by the company under its Patient Access Program. The Deputy Commissioner of State Tax (Appeal) has upheld these adjustments in the recent order.
Financial Implications
The quantum of claims involved is approximately ₹9.24 crore, excluding interest and penalty. However, the company states that the expected overall financial implication cannot be determined at this stage as the matter will be challenged further.
Next Steps
The company intends to challenge the order by filing an appeal before the GST Appellate Tribunal (GSTAT) in due course.